FNDC5 and heart failure: Further study found irisin treatment inhibited TGF‐β/Smad signaling and high glucose‐induced cardiac endothelial‐to‐mesenchymal transition (EndMT), which contribute to cardiac fibrosis and heart failure (Liu et al., 2018).